Vaccine demonstrates potential in delaying relapse of KRAS-mutated pancreatic and colorectal cancers
A vaccine has shown potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phase I trial led by researchers at The University of Texas ...